Puerto Rico Health Center COVID-19 Survey Summary Report

Latest data from January 14, 2022

Number of Health Center respondents = 17 (77% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 11,861
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 99.75%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 3,568
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 99.83%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 0.25% 0.17%
White, Hispanic/Latino Patients 49.11% 49.89%
Black/African American, Non-Hispanic/Latino Patients 0.00% 0.00%
Black/African American, Hispanic/Latino Patients 5.90% 5.02%
Asian Patients3 0.00% 0.00%
American Indian/Alaska Native Patients3 0.00% 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.00% 0.06%
Patients with More Than One Race3 33.46% 31.59%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 11.04% 13.14%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.01% 0.00%
Unreported/Refused to Report Race and Ethnicity 0.22% 0.14%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 1,136
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 100.00%
COVID-19 Immunization Series Completed 1,218
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 99.26%
COVID-19 Immunization Series Additional 9,914
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 99.93%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 0.00% 0.74% 0.07%
White, Hispanic/Latino Patients 56.95% 43.51% 50.04%
Black/African American, Non-Hispanic/Latino Patients 0.00% 0.00% 0.00%
Black/African American, Hispanic/Latino Patients 3.87% 6.40% 7.01%
Asian Patients3 0.09% 0.00% 0.01%
American Indian/Alaska Native Patients3 0.44% 0.16% 0.19%
Native Hawaiian/Other Pacific Islander Patients3 0.09% 0.00% 0.19%
Patients with More Than One Race3 31.51% 32.27% 37.23%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 6.87% 16.58% 5.18%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.00% 0.00% 0.00%
Unreported/Refused to Report Race and Ethnicity 0.18% 0.33% 0.07%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 17.65%
1 to 24 Hours 58.82%
More Than 24 Hours 23.53%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 11.76%
Vaccine confidence 0.00%
Vaccine storage capacity 0.00%
Vaccine supply 17.65%
Other 5.88%
None 64.71%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 29.41%
Average Percent of Health Center Visits Conducted Virtually 24.41%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 47.06%
Number of Mobile Van Sites 8
Number of Pop-up Clinics 24
Number of School-Based Vaccination Sites 1
Number of Family Vaccination Clinics 10

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 5.88%
Refer patients to another organization that provides monoclonal antibody therapies 52.94%
None 41.18%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 11.76%
Patient awareness/education 0.00%
Staffing capacity 0.00%
Therapy administration/onsite logistics 29.41%
Other 0.00%
None 58.82%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 7
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 12,671

Test Kit Distribution Methods4

Metrics Value
Provide to Existing Health Center Patients 71.43%
Provide to General Public Who Came to the Health Center 85.71%
Provide at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 14.29%
Provide at Other Community Events 28.57%
Provide through direct outreach to specific populations (i.e., individuals experiencing homelessness, MSAWs, residents of public housing, individuals with limited English proficiency) 14.29%
Other 14.29%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 0
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 -

Oral Antiviral Medication Distribution by Race and Ethnicity5

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients -
White, Hispanic/Latino Patients -
Black/African American, Non-Hispanic/Latino Patients -
Black/African American, Hispanic/Latino Patients -
Asian Patients3 -
American Indian/Alaska Native Patients3 -
Native Hawaiian/Other Pacific Islander Patients3 -
Patients with More Than One Race3 -
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) -
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) -
Unreported/Refused to Report Race and Ethnicity -

Oral Antiviral Medication Distribution by Special/Vulnerable Population5

Metrics Value
Migratory/Agricultural Workers -
Patients Experiencing Homelessness -
Patients Who Are Residents of Public Housing -
Patients with Limited English Proficiency -
Children Under 18 Years of Age -

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed courses of COVID-19 oral antiviral medication received through the HRSA Health Center COVID-19 Therapeutics Program as the denominator.

Date Last Reviewed:  January 2022